TEX, which is also involved in the progression and metastasis of cancer, has been extensively studied as a biomarker for the diagnosis of cancer and for monitoring the formation of atherosclerosis, but targeting a specific function of TEX could also be a promising therapeutic approach for preventing or delaying cancer recurrence. This evidence concerns the gene TEX46 and cancer.